Orrick Herrington & Sutcliffe, the prestigious international law firm, recently announced the addition of David Sharrow to its Life Sciences and Tech Transactions team as a Partner. Operating out of both the Boston and New York offices, Sharrow’s entry is welcomed as a substantial contribution to the firm.
Apart from being acknowledged for his work in life sciences and tech transactions, Sharrow also carries with him a rich experience in formulating intellectual property strategies. These strategies have been critical in aiding tech companies and life sciences organizations in establishing collaboration, partnering, and licensing agreements. This announcement from Orrick outlines Sharrow’s accomplishments.
Sharrow’s client portfolio expands across various sectors, including life sciences, fintech, artificial intelligence, sustainable and renewable technologies, and cybersecurity. Before joining Orrick, Sharrow spearheaded the licensing, strategic partnering, and commercial transactions group at Gunderson Dettmer.
The move marks a continuing trend of experienced legal professionals like Sharrow being brought on board by tech-centric law firms. As technology and life sciences companies increasingly transform the global business environment, the demand for expert legal counsel in these sectors is quickly escalating.
Summing up, David Sharrow’s move to Orrick is not just a pivotal landmark in his career but also a reflection of the growing intersection between law and technology.